Novavax Inc. Stock Falls Thursday, Underperforms Market

Bird Global Inc

Change company Symbol lookup

Select an option...

BRDS Bird Global Inc

AMH-H American Homes 4 Rent

RNW Renew Energy Global PLC

HARP Harpoon Therapeutics Inc

VIRC Virco Mfg Corp

RVLP RVL Pharmaceuticals PLC

TRGP Targa Resources Corp

RCRT Recruiter.Com Group Inc

VGAS Verde Clean Fuels Inc

DHHC DiamondHead Holdings Corp

Industrials : Ground Transportation | Small Cap Growth

Company profile

Bird Global, Inc. is a micro mobility company, which is engaged in delivering electric transportation solutions for short distances. The Company’s segments include North America, Europe, Middle East and Africa (EMEA) and Other. The Company’s offerings consist of Sharing and Product Sales. Its core vehicle-sharing business and operations (Sharing) provide riders with on-demand access to Bird vehicles (e-scooters and e-bikes), enabling them to locate, unlock, and pay for rides through its mobile application (the Bird App). The Bird App provides an interface, where riders can locate, book, and pay for on-demand rides. In addition to its Sharing business, it offers consumers the opportunity to purchase Bird vehicles for personal use. Its Product Sales business consists primarily of vehicle sales to retail customers. It sells several Bird vehicle models through select retail and wholesale channels. The Company's vehicles include BirdZero, BirdOne, BirdTwo, BirdThree and Bird S.

Novavax Inc. Stock Falls Thursday, Underperforms Market

5:15 pm ET January 26, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) slipped 1.17% to $10.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.76% to 11,512.41 and the Dow Jones Industrial Average rising 0.61% to 33,949.41. This was the stock's third consecutive day of losses. Novavax Inc. closed $90.41 below its 52-week high ($101.39), which the company achieved on February 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.37% to $168.89, Pfizer Inc. (PFE) fell 0.92% to $44.25, and Merck & Co. Inc. (MRK) fell 1.58% to $106.87. Trading volume (5.2 M) remained 1.9 million below its 50-day average volume of 7.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 26, 2023.

(END) Dow Jones Newswires

January 26, 2023 17:15 ET (22:15 GMT)